Protecting your innovation and having a good intellectual property (IP) strategy are key ingredients to have in place before talking to investors, potential partners and expanding your business. In fact, IP is the cornerstone of modern business, used not just to protect scientific and technological rights, but also to gain competitive advantage and drive new revenue opportunities.
Join JLABS, Allen & Overy and O’Melveny for a crash course in patent law and relevance of trade secrets for the life sciences industry. This webinar aims to bring you up to speed on everything you need to know about:
- Patent law (conditions for patent protection, recent evolutions, challenges for personalized medicines).
- The relatively new trade secret legislation, following the adoption of the new EU trade secrets directive.
- Next to an overview of key criterion in order to benefit from trade secret protection, we will discuss some case studies relevant to the life sciences industry and provide practical Do's & Don'ts with respect to how to protect your trade secrets.
Rafi is a Senior Associate in the IP Litigation practice in London. Rafi specialises in contentious life sciences IP litigation and advising clients on regulatory issues in the life sciences sector. Rafi's patent litigation experience includes both representing clients in U.K. proceedings and assisting clients with multi-jurisdictional proceedings and preparation for potential litigation. Rafi has also worked on trade secrets litigation relating to orthopaedic bone cements for one of the leading medical device manufacturers.
Elena is responsible for delivering on the goals and objectives for JLABS in Europe. Her responsibilities include P&L management, external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence and educational programming in collaboration with the team responsible for the site and the region.
Specialising in IP law, Geert conducts litigation, advises on non-litigious matters and assists in negotiating and drafting agreements and transactions in a broad range of sectors, including technology, media, telecom and life sciences. He has more than 30 years of experience in IP litigation before the European, Benelux and Belgian courts, including some landmark cases.
Hassen is an experienced trial lawyer and one of the few patent litigators in the United States with a medical degree. Hassen focuses his practice on representing life sciences companies in contested matters involving pharmaceuticals, biotechnology, and medical devices. He has particular expertise in cases arising under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act.
